712-52-7

Basic information

• Product Name: BROMO-(4-FLUORO-PHENYL)-ACETIC ACID ETHYL ESTER
• Synonyms: BROMO-(4-FLUORO-PHENYL)-ACETIC ACID ETHYL ESTER;ETHYL BROMO-(4-FLUORO-PHENYL)-ACETATE;Benzeneacetic acid, .alpha.-broMo-4-fluoro-, ethyl ester
• CAS NO: 712-52-7
• Molecular Formula: C₁₀H₁₀BrFO₂
• Molecular Weight: 261.0876032
• Mol File: 712-52-7.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 270.4°C at 760 mmHg
• Flash Point: 117.3°C
• Appearance: /
• Density: 1.476g/cm³
• Vapor Pressure: 0.00685mmHg at 25°C
• Refractive Index: 1.529
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: BROMO-(4-FLUORO-PHENYL)-ACETIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: BROMO-(4-FLUORO-PHENYL)-ACETIC ACID ETHYL ESTER(712-52-7)
• EPA Substance Registry System: BROMO-(4-FLUORO-PHENYL)-ACETIC ACID ETHYL ESTER(712-52-7)

Safety Data

• Hazardous Substances Data: 712-52-7(Hazardous Substances Data)

Usage

General Description

Bromo-(4-fluoro-phenyl)-acetic acid ethyl ester is a chemical compound with the formula C10H10BrFO2. It is an ethyl ester derivative of bromo-(4-fluoro-phenyl)-acetic acid, which is a substituted phenylacetic acid. BROMO-(4-FLUORO-PHENYL)-ACETIC ACID ETHYL ESTER is commonly used as a building block in the synthesis of various pharmaceuticals and organic compounds. It is primarily employed as a reagent in chemical reactions for the preparation of other organic compounds. The ethyl ester form of this compound allows for greater solubility and ease of use in organic synthesis reactions. It is important to handle this chemical with care and follow proper safety precautions due to its potential health hazards.

InChI:InChI=1/C10H10BrFO2/c1-2-14-10(13)9(11)7-3-5-8(12)6-4-7/h3-6,9H,2H2,1H3

Upstream product

• 587-88-2 ethyl 2-(4-fluorophenyl)acetate 
• 462-06-6 fluorobenzene 
• 1813-94-1 ethyl 4-fluorobenzoylformate 
• 7550-03-0 ethyl 2-(4-fluorophenyl)-2-hydroxyacetate 
• 64-17-5 ethanol 
• 29270-33-5 2-bromo-2-(4-fluorophenyl)acetic acid 

Downstream Products

• 220531-17-9 (4-Fluoro-phenyl)-(4-nitro-imidazol-1-yl)-acetic acid ethyl ester 
• 1446252-34-1 (E)-ethyl 3-(2-(tert-butoxycarbonylamino)pyridin-4-yl)-2-(4-fluorophenyl) acrylate 
• 1446252-35-2 (E)-2-(4-fluorophenyl)-3-( pyridin-4-yl)acrylic acid 
• 1446252-37-4 (E)-ethyl 3-(2-aminopyridine-4-yl)-2-(4-fluorophenyl)acrylate 
• 1446252-38-5 (E)-ethyl 2-(4-fluorophenyl)-3-(2-(isopropylamino)pyridin-4-yl)acrylate 
• 1446252-39-6 3-[2-(tert-butoxycarbonyl-isopropyl-amino)-pyridin-4-yl]-2-(4-fluoro-phenyl)-acrylic acid ethyl ester 
• 366018-91-9 ethyl 2-amino-2-(4-fluorophenyl)acetate 
• 1813-94-1 ethyl 4-fluorobenzoylformate 
• 1398003-99-0 cis-t-butyl-2-methoxy-3,5-dioxane-6-amino-(N-ethyl-(4-fluorobenzene)-acetate)-heptanoate 

Relevant articles and documents

ANTIVIRAL COMPOUNDS

The present invention relates to novel compounds of general formula (I) wherein R1 to R4 and n have the meanings given in the description and claims, process for preparing these compounds and their use as for treating, preventing or ameliorating viral infections and their use for treating, preventing or ameliorating diseases which are associated with PLA2G16.

MGLUR7 AGONIST COMPOUNDS FOR TREATING MGLUR7- REGULATED DISEASES, DISORDERS, OR CONDITIONS

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof wherein Z, R1, R2, R3, R4, R5 and R6 are as defined in the specification, a process for

Method for treating emesis with ghrelin agonists

The present invention relates to a method comprising administering to a patient diagnosed as being in need of treatment for nausea, emesis, or symptoms associated therewith comprising administering to a patient in need thereof a compound of formula (I) wh